RankingsPricing
  1. US-listed companies
  2. Aldeyra Therapeutics, Inc.
  3. Financials
  4. Stockholders' equity

Aldeyra Therapeutics, Inc.ALDX

Market cap
$300.08M
P/E ratio
SummaryFinancials
Period EndStockholders' equity (Million USD)YoY (%)
Dec 31, 202471-40.73%
Dec 31, 2023120-20.67%
Dec 31, 2022151-26.60%
Dec 31, 2021206+245.72%
Dec 31, 202060+23.76%
Dec 31, 201948-44.49%
Dec 31, 201887+118.73%
Dec 31, 201740+82.92%
Dec 31, 201622-12.98%
Dec 31, 201525+295.90%
Dec 31, 20146

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)